Analysis of long-term outcome of image-guided volumetric modulated arc therapy (VMAT) for primary malignant tumor of the cervical spine. Issue 7 (2nd July 2020)
- Record Type:
- Journal Article
- Title:
- Analysis of long-term outcome of image-guided volumetric modulated arc therapy (VMAT) for primary malignant tumor of the cervical spine. Issue 7 (2nd July 2020)
- Main Title:
- Analysis of long-term outcome of image-guided volumetric modulated arc therapy (VMAT) for primary malignant tumor of the cervical spine
- Authors:
- Jiang, Ping
Zhang, Xile
Jiang, Weijuan
Meng, Na
Aili, Abudureyimujiang
Wang, Junjie - Abstract:
- ABSTRACT: Objective: Retrospective analysis of the long-term clinical outcome and acute toxicity of the primary malignant tumor of cervical spine receiving CBCT image-guided VMAT. Methods: Thirty patients with primary malignant tumor of the cervical spine included in our center, from December 2013 to January 2016, 28 patients were retrospectively studied. The prescription dosage 95% PTV volume dose was 44 Gy, 2.0 Gy/fraction, and a total of 22 times. The median PGTV synchronized volume dose was 60 Gy (45–62.1 Gy), median 2.5 Gy (2–2.7 Gy)/fraction. In volumetric modulated, two arc volumetric modulated arc therapy (VMAT) was used, with spinal cord dosage DMAX < 45 Gy. Early response rate and acute toxicities were analyzed. Result: The follow-up duration was 6–76 months (median 53 months). At the end of follow-up of June 1, 2019, 78.6% (22/28) patients were still alive. 3 and 5-y local control rates were 67.3% and 56.5% while 3 and 5-y OS were both 78.6% in the whole group of patients, respectively. Fourteen patients with chordoma 5-y local control rates and OS were 57.1% and 85.7%, respectively. Nine patients with giant-cell tumor of bone had a 5-y local control rate and OS were 77.8% and 85.7%, respectively. The response rate for moderate pain or above was 80% (8/10). Eleven patients (39.3%) suffered from grade 1 acute skin toxicity. Twenty-four patients (85.7%) had grade 1/2 mucositis. No radiation-induced spinal cord injury was found. Conclusion: The image-guided VMAT forABSTRACT: Objective: Retrospective analysis of the long-term clinical outcome and acute toxicity of the primary malignant tumor of cervical spine receiving CBCT image-guided VMAT. Methods: Thirty patients with primary malignant tumor of the cervical spine included in our center, from December 2013 to January 2016, 28 patients were retrospectively studied. The prescription dosage 95% PTV volume dose was 44 Gy, 2.0 Gy/fraction, and a total of 22 times. The median PGTV synchronized volume dose was 60 Gy (45–62.1 Gy), median 2.5 Gy (2–2.7 Gy)/fraction. In volumetric modulated, two arc volumetric modulated arc therapy (VMAT) was used, with spinal cord dosage DMAX < 45 Gy. Early response rate and acute toxicities were analyzed. Result: The follow-up duration was 6–76 months (median 53 months). At the end of follow-up of June 1, 2019, 78.6% (22/28) patients were still alive. 3 and 5-y local control rates were 67.3% and 56.5% while 3 and 5-y OS were both 78.6% in the whole group of patients, respectively. Fourteen patients with chordoma 5-y local control rates and OS were 57.1% and 85.7%, respectively. Nine patients with giant-cell tumor of bone had a 5-y local control rate and OS were 77.8% and 85.7%, respectively. The response rate for moderate pain or above was 80% (8/10). Eleven patients (39.3%) suffered from grade 1 acute skin toxicity. Twenty-four patients (85.7%) had grade 1/2 mucositis. No radiation-induced spinal cord injury was found. Conclusion: The image-guided VMAT for primary malignant tumor of the cervical spine provided a satisfactory long-term local control rate. … (more)
- Is Part Of:
- Cancer biology & therapy. Volume 21:Issue 7(2020)
- Journal:
- Cancer biology & therapy
- Issue:
- Volume 21:Issue 7(2020)
- Issue Display:
- Volume 21, Issue 7 (2020)
- Year:
- 2020
- Volume:
- 21
- Issue:
- 7
- Issue Sort Value:
- 2020-0021-0007-0000
- Page Start:
- 623
- Page End:
- 628
- Publication Date:
- 2020-07-02
- Subjects:
- Cervical spine -- chordoma -- giant-cell tumor of bone -- VMAT -- EBRT
616.99406 - Journal URLs:
- http://www.tandfonline.com/ ↗
- DOI:
- 10.1080/15384047.2020.1743149 ↗
- Languages:
- English
- ISSNs:
- 1538-4047
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.456700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 22952.xml